Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...
On the mild side for our Friday afternoon… topping out in the mid to upper 50s and a few low 60s across north Mississippi, so make some plans to enjoy! We have our initial cold front sweeping through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback